IlettKFKristensenJHHackettLPPaechMKohanRRamponoJ.Distribution of venlafaxine and its O-desmethyl metabolite in human milk and their effects in breastfed infants. Br J Clin Pharmacol2002;53: 17–22.
2.
KristensenJHIlettKFHackettL PYappPPaechMBeggEJ.Distribution and excretion of fluoxetine and norfluoxetine in human milk. Br J Clin Pharmacol1999;48:521–7.
3.
KristensenJHHackettL PKohanRPaechMJIlettKF.The amount of fluvoxamine in milk is unlikely to be a cause of adverse effects in breastfed infants. J Hum Lact2001;18:139–43.
4.
RamponoJKristensenJHHackettLPPaechMKohanRIlettKF.Citalopram and demethylcitalopram in human milk: Distribution, excretion and effects in breast fed infants. Br J Clin Pharmacol2000;50:263–8.
5.
BeggEJDuffullSBSaundersDAButtimoreRCIlettKFHackettLPParoxetine in human milk. Br J Clin Pharmacol1999;48:142–7.
6.
AtkinsonHCBeggEJ.Prediction of drug distribution into human milk from physicochemical characteristics. Clin Pharmacokinet1990;18:151–67.
7.
LarsenLAItoSKorenG.Prediction of milk/plasma concentration ratio of drugs. Ann Pharmacother2003;37:1299–306. DOI 10.1345/aph.1C379.
8.
SpigsetOCarieborgLOhmanRNorstromA.Excretion of citalopram in breast milk. Br J Clin Pharmacol1997;44:295–8.
9.
HaggSGranbergKCarleborgL.Excretion of fluvoxamine into breast milk. Br J Clin Pharmacol2000;49:286–8.
10.
OhmanRHaggSCarleborgLSpigsetO.Excretion of paroxetine into breast milk. J Clin Psychiatry1999;60:519–23.
